Medizinische Klinik

, Volume 92, Issue 2, pp 106–111 | Cite as

Sterbebegleitende Medizin — Grundlagen und Perspektiven

  • Bernhard Knupp
  • Wolfgang Stille
Standorte

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Ahmedzai, S.: Palliative care in oncology: making quality the endpoint. Ann. Oncol. (1990), 396–398.Google Scholar
  2. 2.
    Albrecht, E.: Medizinische Sterbebegleitung im Hospiz. Dtsch. Ärztebl. 87 (1990), B32–33.Google Scholar
  3. 3.
    Armstrong, D.: What do patients want? Brit. med. J. 303 (1991), 261–262.PubMedCrossRefGoogle Scholar
  4. 4.
    Ashby, M., B. Stoffell: Therapeutic ratio and defined phases: proposal of ethical framework for palliative care. Brit. med. J. 302 (1991), 1322–1324.PubMedCrossRefGoogle Scholar
  5. 5.
    Baines, M., D. J. Oliver, R. L. Carter: Medical management of intestinal obstruction in patients with advanced maligant disease—a clinical and pathological study. Lancet (1985), 990–993.Google Scholar
  6. 6.
    Barton, D.: Dying and death. A clinical guide for care-givers. Williams & Wilkins, Baltimore 1977.Google Scholar
  7. 7.
    Binsack, T.: Ernährung und Flüssigkeitszufuhr bei Todkranken. Münch. med. Wschr. 136 (1994), 550–551.Google Scholar
  8. 8.
    Briggs, P. G.: Who needs a hospice? Med. J. Aust. 156 (1992), 417–420.PubMedGoogle Scholar
  9. 9.
    Bron, B.: Angst und Depression bei unheilbar Kranken und Sterbenden. Dtsch. med. Wschr. 112 (1987), 148–154.PubMedGoogle Scholar
  10. 10.
    Bundesärztekammer: Richtlinien der Bundesärztekammer für die ärztliche Sterbebegleitung. Dtsch. Ärztebl. 90 (1993), A2404–2406.Google Scholar
  11. 11.
    Cohen, M. H., A. Johnston-Anderson, S. H. Krasnow, R. G. Wadleigh: Treatment of intractable dyspnea: clinical and ethical issues. Cancer Invest. 10 (1992), 317–321.PubMedCrossRefGoogle Scholar
  12. 12.
    Coyle N., J. Adelhardt, K. M. Foley, R. K. Portenoy: Caracter of terminal illness in the advanced cancer patient: pain and other symptoms during the last four weeks of life. J. Pain Sympt. Manag. 5 (1990), 83–93.CrossRefGoogle Scholar
  13. 13.
    Davis, C.: Dysphea in palliative care. Brit. med. J. 305 (1992), 1158.PubMedCrossRefGoogle Scholar
  14. 14.
    Donner, B., M. Zenz: Medikamentöse Schmerztherapie. Dtsch. Ärztebl. 91 (1994), B1270–1274.Google Scholar
  15. 15.
    Doyle, D., G. W. C. Hanks, N. Macdonald (eds.): Oxford textbook of palliative medicine. Oxford University Press, Oxford 1993.Google Scholar
  16. 16.
    Emanuel, E. J., L. L. Emanuel: The economics of dying. The illusion of cost savings at the end of life. New Engl. J. Med. 330 (1994), 540–544.PubMedCrossRefGoogle Scholar
  17. 17.
    Expert Working Group of the European Association for Palliative Care: Morphine in cancer pain: modes of administration. Brit. med. J. 312 (1996), 823–826.Google Scholar
  18. 18.
    Farncombe, F., S. Carter: The use of nebulized opioids for breathlessness. Palliat. Med. 8 (1994), 306–312.PubMedCrossRefGoogle Scholar
  19. 19.
    Finlay, I. G.: Oral symptoms and candida in the terminally ill. Brit. med. J. 292 (1986), 592–593.CrossRefGoogle Scholar
  20. 20.
    Fowlie, M.: Quality of life in advanced cancer: the benefit of asking the patient. Palliat. Med. 3 (1989), 55–59.CrossRefGoogle Scholar
  21. 21.
    Horwich, A.: Radiotherapy update. Brit. med. J. 304 (1992), 1554–1557.PubMedCrossRefGoogle Scholar
  22. 22.
    Hürny, C.: Palliative care in high-tech medicine: defining the point of no return. Supp. Care Cancer 2 (1994), 3–4.CrossRefGoogle Scholar
  23. 23.
    Jamie, H.: Physician attitudes and practice in cancer pain management. Ann. intern. Med. 119 (1993), 121–126.Google Scholar
  24. 24.
    Kloke, M., K. Höffken, A. Meyer-Jürshof, H. Schneemann: Orale Morphintherapie schwerer Tumorschmerzen. Dtsch. Ärztebl. 88 (1991), B2772–2779.Google Scholar
  25. 25.
    Knupp, B.: Leben und Sterben mit AIDS. Gespräche mit Patienten im Krankenhaus. Verlag Akademischer Schriften, Frankfurt/M. 1990.Google Scholar
  26. 26.
    Knupp, B.: Sterben mit AIDS. Behandlung und Betreuung terminaler HIV-Patienten. In: L’age-Stehr, J., E. B. Helm (Hrsg.). AIDS und die Vorstadien. Springer, Heidelberg — Berlin — New York 1994, S. 1–14.Google Scholar
  27. 27.
    Knupp, B., R. Dönges, B. Heun, I. Wellbrock, H. Hermann, H. Jürgen-Lohmann, W. Stille: Hospize und AIDS — Das Franziskus-Haus in Frankfurt am Main: Analyse der ersten zwei Jahre. AIFO 11 (1996), 67–74.Google Scholar
  28. 28.
    Knupp, B., W. Stille (Hrsg.): Sterben und Tod in der Medizin. Wissenschaftliche Verlagsgesellschaft, Stuttgart 1996.Google Scholar
  29. 29.
    Lichter, I., E. Hunt: The last 48 hours of life. J. palliat. Care 6 (1990), 7–11.PubMedGoogle Scholar
  30. 30.
    Lombard, D. J., D. J. Oliver: The use of opioid analgesics in the last 24 hours of life of patients with advanced cancer. Palliat. Med. 3 (1989), 27–29.CrossRefGoogle Scholar
  31. 31.
    Maddocks, I.: Changing concepts in palliative care. Med. J. Aust. 152 (1990), 535–539.PubMedGoogle Scholar
  32. 32.
    Malcolm, J. A., D. C. Sutherland: AIDS palliative care demands a new model. Med. J. Aust. 157 (1992), 572.PubMedGoogle Scholar
  33. 33.
    Miller, R. D., R. Krech, T. D. Walsh: The role of a palliative care service family conference in the management of the patient with advanced cancer. Palliat. Med. 5 (1991), 34–39.CrossRefGoogle Scholar
  34. 34.
    Pichlmayer, H., H.-U. Zieren, R. Böhm-Porath: Die Ertassung von Lebensqualität. In: Pichlmayer, H. (Hrsg.): Palliative Krebstherapie. Springer, Berlin-Heidelberg-New York 1991, S. 55–62.Google Scholar
  35. 35.
    Porter, J., H. Jick: Addiction rare in patients treated with narcotics. New Engl. J. Med. 302 (1980), 123.PubMedGoogle Scholar
  36. 36.
    Price, P.: Prospective randomized trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases. Radiother. Oncol. 6 (1986), 247–255.PubMedCrossRefGoogle Scholar
  37. 37.
    Quill, T. E.: Death and dignity: a case of individualized decision making. New Engl. J. Med. 324 (1991), 691–694.PubMedGoogle Scholar
  38. 38.
    Regnard, C., K. Mannix: Reduced hydration or feeding in advanced desease — a flow diagram. Palliat. Med. 5 (1991), 161–164.Google Scholar
  39. 39.
    Ripamonti, C., E. Bruera: Transdermal and inhalatory route of opioid administration: the potential application in the cancer patient. Palliat. Med. 6 (1992), 98–104.CrossRefGoogle Scholar
  40. 40.
    Rubens, R. D.: Appropriate chemotherapy for palliation advanced cancer. Brit. med. J. 304 (1992), 35–40.PubMedCrossRefGoogle Scholar
  41. 41.
    Schmähl, D., H. Ehrhart (Hrsg.): Ethik in der Behandlung Krebskranker und Schwerkranker. Reihe Aktuelle Onkologie 39. W. Zuckschwerdt, München-Bern-Wien 1987.Google Scholar
  42. 42.
    Siegler, M., A. J. Weisbard: Against the emerging stream. Should fluids and nutritional support be discontinued? Arch. intern. Med. 145 (1985), 129–131.PubMedCrossRefGoogle Scholar
  43. 43.
    Statistisches Bundesamt Wiesbaden: Todesursachenstatistik 1993. Fachserie 12, Reihe 4 (1995).Google Scholar
  44. 44.
    Strubelt, O.: Vereinfachte Verschreibung von Betäubungsmitteln. Die Vorschriften der 4. Novelle der Betäubungsmittel-Verschreibungsverordnung. Dtsch. Ärztebl. 90 (1993), B1292–1297.Google Scholar
  45. 45.
    Twycross, R., S. Lack: Therapeutics in terminal cancer. 2nd ed. Curchill Livingstone, Edinburgh 1990.Google Scholar
  46. 46.
    Twycross, R., I. Lichter: The terminal phase. In: Doyle, D., G. W. C. Hanks, N. MacDonald (eds.): Oxford textbook of palliative medicine. Oxford University Press, Oxford 1993, p. 651–661.Google Scholar
  47. 47.
    Twycross, R.: The risks and benefits of corticosteroids in advanced cancer. Drug Safety 11 (1994), 163–178.PubMedCrossRefGoogle Scholar
  48. 48.
    Vachon, M. L. S.: Counselling and psychotherapy in palliative-hospice care: a review. Palliat. Med. 2 (1988), 36–50.CrossRefGoogle Scholar
  49. 49.
    Ventafridda V., C. Ripamonti, F. De Conno, M. Tamburini, B. R. Cassileth: Symptom prevalence and control during cancer patients’ last days of life. J. palliat. Care 6 (1990), 7–11.PubMedGoogle Scholar
  50. 50.
    Wanzer, S. H., S. J. Adelstein, R. E. Cranford: The physician’s responsibility toward hopelessly ill patients. New Engl. J. Med. 310 (1984), 955–959.PubMedCrossRefGoogle Scholar
  51. 51.
    Wilcoc, A., R. Corcorani: Saftey and efficiancy of nebulized lignocaine in patients with cancer and breathlessness. Palliat. Med. 8 (1994), 33–38.Google Scholar
  52. 52.
    World Health Organisation: Cancer pain relief. World Health Organisation, Geneva 1986.Google Scholar
  53. 53.
    Zech, D., R. Sabatowski, L. Radbruch: Hospize und Palliativeinrichtungen in Deutschland. Dtsch. Ärztebl. 91 (1994), A814–818.Google Scholar

Copyright information

© Urban & Vogel 1997

Authors and Affiliations

  • Bernhard Knupp
    • 1
  • Wolfgang Stille
    • 1
  1. 1.Medizinische Klinik IIIKlinikum der Johann Wolfgang Goethe-UniversitätFrankfurt am Main

Personalised recommendations